These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22832343)

  • 1. Mutations in TPM2 and congenital fibre type disproportion.
    Clarke NF; Waddell LB; Sie LT; van Bon BW; McLean C; Clark D; Kornberg A; Lammens M; North KN
    Neuromuscul Disord; 2012 Nov; 22(11):955-8. PubMed ID: 22832343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New morphologic and genetic findings in cap disease associated with beta-tropomyosin (TPM2) mutations.
    Ohlsson M; Quijano-Roy S; Darin N; Brochier G; Lacène E; Avila-Smirnow D; Fardeau M; Oldfors A; Tajsharghi H
    Neurology; 2008 Dec; 71(23):1896-901. PubMed ID: 19047562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined cap disease and nemaline myopathy in the same patient caused by an autosomal dominant mutation in the TPM3 gene.
    Malfatti E; Schaeffer U; Chapon F; Yang Y; Eymard B; Xu R; Laporte J; Romero NB
    Neuromuscul Disord; 2013 Dec; 23(12):992-7. PubMed ID: 24095155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in TPM3 are a common cause of congenital fiber type disproportion.
    Clarke NF; Kolski H; Dye DE; Lim E; Smith RL; Patel R; Fahey MC; Bellance R; Romero NB; Johnson ES; Labarre-Vila A; Monnier N; Laing NG; North KN
    Ann Neurol; 2008 Mar; 63(3):329-37. PubMed ID: 18300303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and phenotype of patients carrying TPM2 and TPM3 gene mutations in a cohort of 94 patients with congenital myopathy.
    Citirak G; Witting N; Duno M; Werlauff U; Petri H; Vissing J
    Neuromuscul Disord; 2014 Apr; 24(4):325-30. PubMed ID: 24507666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actin mutations are one cause of congenital fibre type disproportion.
    Laing NG; Clarke NF; Dye DE; Liyanage K; Walker KR; Kobayashi Y; Shimakawa S; Hagiwara T; Ouvrier R; Sparrow JC; Nishino I; North KN; Nonaka I
    Ann Neurol; 2004 Nov; 56(5):689-94. PubMed ID: 15468086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenesis of ACTA1-related congenital fiber type disproportion.
    Clarke NF; Ilkovski B; Cooper S; Valova VA; Robinson PJ; Nonaka I; Feng JJ; Marston S; North K
    Ann Neurol; 2007 Jun; 61(6):552-61. PubMed ID: 17387733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel TPM3 mutation in a family with cap myopathy and review of the literature.
    Schreckenbach T; Schröder JM; Voit T; Abicht A; Neuen-Jacob E; Roos A; Bulst S; Kuhl C; Schulz JB; Weis J; Claeys KG
    Neuromuscul Disord; 2014 Feb; 24(2):117-24. PubMed ID: 24239060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myasthenia.
    Munot P; Lashley D; Jungbluth H; Feng L; Pitt M; Robb SA; Palace J; Jayawant S; Kennet R; Beeson D; Cullup T; Abbs S; Laing N; Sewry C; Muntoni F
    Neuromuscul Disord; 2010 Dec; 20(12):796-800. PubMed ID: 20951040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cap disease caused by heterozygous deletion of the beta-tropomyosin gene TPM2.
    Lehtokari VL; Ceuterick-de Groote C; de Jonghe P; Marttila M; Laing NG; Pelin K; Wallgren-Pettersson C
    Neuromuscul Disord; 2007 Jun; 17(6):433-42. PubMed ID: 17434307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion.
    Lawlor MW; Dechene ET; Roumm E; Geggel AS; Moghadaszadeh B; Beggs AH
    Hum Mutat; 2010 Feb; 31(2):176-83. PubMed ID: 19953533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital myopathies with secondary neuromuscular transmission defects; a case report and review of the literature.
    Rodríguez Cruz PM; Sewry C; Beeson D; Jayawant S; Squier W; McWilliam R; Palace J
    Neuromuscul Disord; 2014 Dec; 24(12):1103-10. PubMed ID: 25127990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel autosomal dominant TPM3 mutation causes a combined congenital fibre type disproportion-cap disease histological pattern.
    Bevilacqua JA; Contreras JP; Trangulao A; Hernández Ú; Brochier G; Díaz J; Hughes R; Campero M; Romero NB
    Neuromuscul Disord; 2022 Aug; 32(8):687-691. PubMed ID: 35688744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An adult with a rare form of congenital fiber type disproportion.
    Anandan C; Milone M
    Muscle Nerve; 2018 Jan; 57(1):E97-E99. PubMed ID: 28881016
    [No Abstract]   [Full Text] [Related]  

  • 15. Congenital myotonic dystrophy can show congenital fiber type disproportion pathology.
    Tominaga K; Hayashi YK; Goto K; Minami N; Noguchi S; Nonaka I; Miki T; Nishino I
    Acta Neuropathol; 2010 Apr; 119(4):481-6. PubMed ID: 20179953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Congenital myopathies].
    Cabello A; Ricoy-Campo JR
    Rev Neurol; 2003 Oct 16-31; 37(8):779-86. PubMed ID: 14593641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies.
    Marttila M; Lehtokari VL; Marston S; Nyman TA; Barnerias C; Beggs AH; Bertini E; Ceyhan-Birsoy O; Cintas P; Gerard M; Gilbert-Dussardier B; Hogue JS; Longman C; Eymard B; Frydman M; Kang PB; Klinge L; Kolski H; Lochmüller H; Magy L; Manel V; Mayer M; Mercuri E; North KN; Peudenier-Robert S; Pihko H; Probst FJ; Reisin R; Stewart W; Taratuto AL; de Visser M; Wilichowski E; Winer J; Nowak K; Laing NG; Winder TL; Monnier N; Clarke NF; Pelin K; Grönholm M; Wallgren-Pettersson C
    Hum Mutat; 2014 Jul; 35(7):779-90. PubMed ID: 24692096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variants in tropomyosins TPM2 and TPM3 causing muscle hypertonia.
    Wallgren-Pettersson C; Jokela M; Lehtokari VL; Tyynismaa H; Sainio MT; Ylikallio E; Tynninen O; Pelin K; Auranen M
    Neuromuscul Disord; 2024 Feb; 35():29-32. PubMed ID: 38219297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal actin binding of aberrant β-tropomyosins is a molecular cause of muscle weakness in TPM2-related nemaline and cap myopathy.
    Marttila M; Lemola E; Wallefeld W; Memo M; Donner K; Laing NG; Marston S; Grönholm M; Wallgren-Pettersson C
    Biochem J; 2012 Feb; 442(1):231-9. PubMed ID: 22084935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies.
    Zhou H; Jungbluth H; Sewry CA; Feng L; Bertini E; Bushby K; Straub V; Roper H; Rose MR; Brockington M; Kinali M; Manzur A; Robb S; Appleton R; Messina S; D'Amico A; Quinlivan R; Swash M; Müller CR; Brown S; Treves S; Muntoni F
    Brain; 2007 Aug; 130(Pt 8):2024-36. PubMed ID: 17483490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.